Format

Send to:

Choose Destination
See comment in PubMed Commons below
Acta Gastroenterol Belg. 1990 Jul-Aug;53(4):402-8.

The rationale for using ursodeoxycholic acid in chronic liver disease.

Author information

  • 1Service de Médecine Interne, Hôpital de Jolimont, Haine St Paul, Belgique.

Abstract

The authors make a review of the literature and of their personal experience about the possible mechanisms of action and the beneficial therapeutic effects of ursodeoxycholic acid in primary biliary cirrhosis. They postulate that owing to its hydrophilic properties, ursodeoxycholic acid is more efficiently absorbed by the ileum than the other bile acids, so replacing the other bile acids in the bile acid pool, and that ursodeoxycholic acid is less toxic for hepatocytes than the other bile acids accumulating in the plasma and is also a choleretic.

PMID:
2096588
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk